Purchase Order SPE2DP25P0670
- Not listed
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a firm fixed price purchase order valued at $10,585.32 to Eagle Pharmaceuticals, Inc. for Dantrolene Sodium F, with performance expected to conclude by September 19, 2025. This contract is designated as a Total Small Business set-aside and was awarded on September 4, 2025, with work to be performed in Westwood, New Jersey. Eagle Pharmaceuticals, a specialized pharmaceutical manufacturer headquartered in...
- The U.S. Department of Defense Medical Supply Chain has awarded a $10,585.32 firm fixed-price purchase order to Eagle Pharmaceuticals, Inc. for Dantrolene Sodium F, a critical injectable medication. The contract, designated as a Total Small Business set-aside, was awarded on September 3, 2025, with an ultimate completion date of September 18, 2025. Performance will take place in Westwood, New Jersey. Eagle Pharmaceuticals, a specialized pharmaceutical manufacturer headquartered in Woodcliff...
- This federal contract award, valued at $58,219.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer, for the supply of Dantrolene Sodium F medication. The contract has a total small business set-aside designation. The original solicitation, which was posted on March 27, 2025 and had a due date of April 2, 2025, requested the procurement of 33 units of Dantrolene Sodium F medication across 11 line...
- This federal contract award, valued at $5,292.66, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dantrolene Sodium powder, a medication used to treat certain muscle disorders. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
- The federal contract award SPE2D018D0006|SPE2D021F0173 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Eagle Pharmaceuticals, Inc. The $87,282.92 firm fixed-price delivery order contract is for the provision of other medical supplies, specifically the 250mg injectable medication Ryanodex, used to treat and prevent malignant hyperthermia in high-risk patients. This contract does not have a set-aside designation, indicating Eagle Pharmaceuticals...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract is for the supply of Ryanodex 250 mg vials, a critical injectable medication used to treat and prevent malignant hyperthermia. The contract has a ceiling value of $7,056.88 and an ultimate completion date of May 1, 2025. Eagle Pharmaceuticals holds a significant Federal Supply Schedule (FSS)...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $5,292.66 by the Defense Logistics Agency's Medical Supply Chain for the supply of Dantrolene Sodium Powder. The contract, issued on February 28, 2025, carries an ultimate completion date of March 21, 2025, and represents a firm fixed-price arrangement with no set-aside designation. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract is for the supply of Ryanodex, a 250mg injectable medication used to treat and prevent malignant hyperthermia in high-risk patients. The contract has a ceiling value of $5,080.62 and an ultimate completion date of December 10, 2024. This contract is not associated with any set-aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Medical Supply Chain for the supply of Fosphenytoin 500 mg PE/10 mL (10 mL vials) with a ceiling value of $1,189.39. This firm fixed-price delivery order is not set-aside and is scheduled for ultimate completion by September 10, 2025. The award represents a routine pharmaceutical procurement fulfilling federal medical...
- The U.S. Defense Logistics Agency Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Donnatal Elixir 120ml pharmaceutical product. This firm fixed-price delivery order has a ceiling value of $1,209.76 and an ultimate completion date of June 2, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with performance taking...
The U.S. Department of Defense, through its Medical Supply Chain division, awarded a $10,585.32 firm fixed-price purchase order to Eagle Pharmaceuticals, Inc. for Dantrolene Sodium F on September 4, 2025. The contract, designated as a Total Small Business set-aside, has an ultimate completion date of September 19, 2025 and will be performed in Westwood, New Jersey. Eagle Pharmaceuticals, a specialized pharmaceutical manufacturer headquartered in Woodcliff Lake, New Jersey, has established itself as a critical supplier of injectable medications to federal agencies, particularly the Department of Defense and Department of Veterans Affairs. This award supports the Department of Defense's medical readiness initiatives by providing Dantrolene Sodium, a specialized pharmaceutical product used to treat and prevent malignant hyperthermia. The purchase order represents a continuation of Eagle Pharmaceuticals' ongoing role as a prime contractor supplying critical injectable medications through the federal medical supply chain. The company maintains significant federal contracting relationships, including a $30.9 million Federal Supply Schedule contract with the VA Veterans Health Administration effective through January 2029, demonstrating its established position as a trusted provider of specialized pharmaceutical products to federal healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 9/4/25 |